Point of Care Diagnostics Market By Product, By Mode Of Prescription, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

Point of Care Diagnostics Market By Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs Abuse Testing Kits, Others), By Mode Of Prescription (Prescription Based Devices, Otc Based Devices), By End User (Professional Diagnostic Centers, Research Laboratories, Home Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

The point-of-care (POC) tests refer to the diagnostic procedures, which are conducted outside laboratories. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drug abuse testing, diagnosis of infectious diseases, and pregnancy testing. In addition, cardiac markers, fecal occult blood tests, and blood gases tests can also be performed using POC diagnostic devices.
An increase in the prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rising health awareness are major factors that drive the global point-of-care diagnostic market. In addition, technological advancements in POC diagnostic devices and introduction of home-based POC devices; and an increase in healthcare spending support the growth of the market. However, stringent government regulations for the approval of POC diagnostic devices and reimbursement issues for the POC devices are some of the major restraints that obstruct the growth of the market. Furthermore, developing countries, such as China and India provide huge growth opportunities to the global point-of-care diagnostics market.
The global point-of-care diagnostic market is segmented on the basis of product, end-user, mode of prescription, and region.
By product, the point-of-care diagnostic kit market is segmented into glucose monitoring kit, infectious diseases testing kit, pregnancy, and fertility testing kit, hematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, cholesterol test strips, drug of abuse testing kit, and others. Among these, the glucose monitoring kits segment dominates the global point-of-care diagnostics market owing to the increase in the prevalence of diabetes globally. However, the infectious disease testing kit is the fastest-growing segment during the forecast period. This is due to the rise in awareness about the various infectious diseases, rapid product launches, and initiatives implemented by government organizations for free check-ups in public places.
By end-user, the global point-of-care diagnostics market is segmented into professional diagnostic centers, research laboratories, homes, and others,  Among these end users, the professional diagnostic centers dominate the global point-of-care diagnostics market.
By mode of prescription, the global point-of-care diagnostics market is segmented into prescription-based point-of-care diagnostics and over-the-counter (OTC)-based point-of-care diagnostics market. The prescription-based point-of-care diagnostics are most frequently used in healthcare facilities and prescribed by healthcare professionals.
Geographically, the market is segmented across four major regions, such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the point-of-care diagnostic market. Asia-Pacific region is expected to emerge as the region with maximum growth potential due to the growth in the focus of key players in emerging economies and improvement in healthcare infrastructure in the region.
The report provides extensive competitive analysis and profiles of key market players operating in the point-of-care diagnostic market, such as Abbott Laboratories, Siemens AG, Hoffmann-La Roche Ltd, SINOCARE INC., Johnson & Johnson, Sysmex Corporation, NOVA Biomedical, Danaher Corporation, Becton Dickinson, and Company, and Bio-Rad laboratories.

KEY BENEFITS FOR STAKEHOLDERS
 
?The report provides an in-depth analysis of the global point-of-care diagnostic Kit market size along with the current trends and future estimations to elucidate the imminent investment pockets.
?It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
?A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
?The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Point of Care Diagnostic Kit market.

Key Market Segments

By BY PRODUCT
? Glucose Monitoring Kits
? Infectious Diseases Testing Kits
? Pregnancy And Fertility Testing Kits
? Hematology Testing Kits
? Cardiometabolic Monitoring Kits
? Urinalysis Testing Kits
? Cholesterol Test Strips
? Others
? Drugs Abuse Testing Kits

By BY MODE OF PRESCRIPTION
? Prescription Based Devices
? Otc Based Devices

By BY END USER
? Professional Diagnostic Centers
? Research Laboratories
? Home Care
? Others

By BY REGION
? North America
? U.S.
? Canada
? Mexico
? Europe
? Germany
? France
? UK
? Italy
? Spain
? Rest of Europe
? Asia Pacific
? Japan
? China
? Australia
? India
? South Korea
? Rest Of Asia Pacific
? LAMEA
? Brazil
? Saudi Arabia
? South Africa
? Rest of LAMEA
? Key Market Players
? Johnson and Johnson
? sysmex corporation
? Nova Biomedical
? Danaher Corporation
? Becton Dickinson and Company
? bioMrieux SA
? Abbott Laboratories
? Siemens AG
? Hoffmann La Roche Ltd
? Sinocare Inc.